Bank of America Downgrades Seattle Genetics To Underperform

Analysts at Bank of America downgraded Seattle Genetics

from Neutral to Underperform. The target price for Seattle Genetics has been lowered from $ $40 to $34. Seattle Genetics shares have dropped 14.48% over the past 52 weeks, while the S&P 500 index has jumped 16.68% in the same period. Seattle Genetics' shares dropped 2.27% to $37.52 in pre-market trading.